Log In
Print this Print this

pTVG-HP (MVI-816)

  Manage Alerts
Collapse Summary General Information
Company Madison Vaccines Inc.
DescriptionPlasmid DNA vaccine carrying human prostatic acid phosphatase (PAP; ACPP)
Molecular Target
Mechanism of ActionVaccine; Immunotherapy
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase II
Standard IndicationProstate cancer
Indication DetailsTreat hormone naive, biochemically recurrent prostate cancer; Treat metastatic castration-resistant prostate cancer (CRPC); Treat metastatic prostate cancer; Treat non-metastatic prostate cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today